Instituto de Ensino e Pesquisa do Hospital da Bahia
Salvador, Bahia, Brazil
About Instituto de Ensino e Pesquisa do Hospital da Bahia
Top Sponsors
Top Collaborators
Trials By Phase
Recruitment Status
Top Conditions
Intervention Types
Top Intervention Names
Trials By Gender
Lead Sponsor
# Trials
Boehringer Ingelheim
2
Amgen
1
Brazilian Clinical Research Institute
1
Clinical Trials at Instituto de Ensino e Pesquisa do Hospital da Bahia
During the past decade, Instituto de Ensino e Pesquisa do Hospital da Bahia conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 1 clinical trials were completed, i.e. on
average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 1 clinical trials were completed. i.e. 33.3%
of trials that started reached the finish line.
EMPACT-MI: A Study to Test Whether Empagliflozin Can Lower the Risk of Heart Failure and Death in People Who Had a Heart Attack (Myocardial Infarction)
A Cross-sectional Study of Lipoprotein(a) Levels in Patients With Documented History of Atherosclerotic Cardiovascular Disease (ASCVD)
2022-04-19
2024-01-05
Recruiting
40,000
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Instituto de Ensino e Pesquisa do Hospital da Bahia"
#1 collaborator was "Beneficência Portuguesa de São Paulo" with 1 trials as a collaborator, "Brazilian Research In Intensive Care Network" with 1 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator, "Hospital Alemão Oswaldo Cruz" with 1 trials as a collaborator and "Hospital Israelita Albert Einstein" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 8 trials.
Clinical Trials Conditions at Instituto de Ensino e Pesquisa do Hospital da Bahia
According to Clinical.Site data, the most researched conditions in "Instituto de Ensino e Pesquisa do Hospital da Bahia" are
"Atherosclerotic Cardiovascular Disease" (1 trials), "Atrial Fibrillation" (1 trials), "Coronavirus Infection" (1 trials), "Myocardial Infarction" (1 trials) and "Stroke" (1 trials). Many other conditions were trialed in "Instituto de Ensino e Pesquisa do Hospital da Bahia" in a lesser frequency.
Clinical Trials Intervention Types at Instituto de Ensino e Pesquisa do Hospital da Bahia
Most popular intervention types in "Instituto de Ensino e Pesquisa do Hospital da Bahia" are "Drug" (2 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Empagliflozin" (1 trials), "Group 1: Rivaroxaban 20mg/d followed by enoxaparin/unfractionated heparin when needed" (1 trials), "Group 2: control group with enoxaparin 40mg/d" (1 trials), "Lp(a) Screening" (1 trials) and "Placebo" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Instituto de Ensino e Pesquisa do Hospital da Bahia
The vast majority of trials in "Instituto de Ensino e Pesquisa do Hospital da Bahia" are
4 trials for "All" genders.
Clinical Trials Status at Instituto de Ensino e Pesquisa do Hospital da Bahia
Currently, there are NaN active trials in "Instituto de Ensino e Pesquisa do Hospital da Bahia".
undefined are not yet recruiting,
1 are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in Instituto de Ensino e Pesquisa do Hospital da Bahia,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Instituto de Ensino e Pesquisa do Hospital da Bahia, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 1 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 1 trials that are defined as “Not Applicable".